FILE:CELG/CELG-8K-20120823172724.txt.gz
EVENTS:	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
TEXT:
ITEM: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
 
 
 
 
 
On August 21, 2012, Celgene Corporation (the "Company") announced that, effective September 1, 2012, Graham Burton, MBBS, FRCP, will relinquish his responsibilities as Senior Vice President Global Regulatory Affairs, Pharmacovigilance, Corporate Quality and Compliance. In his transition to retirement, Dr. Burton will take on new assignments that capitalize on his extensive global expertise and worldwide stakeholder relationships.
 
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 


